TuHURA Biosciences (HURA) Operating Leases (2024 - 2026)

TuHURA Biosciences' Operating Leases history runs 3 years deep, the most recent figure standing at $250075.0 for Q1 2026.

• In Q1 2026, Operating Leases changed N/A year-over-year to $250075.0; the TTM figure through Mar 2026 stood at $250075.0 (changed N/A YoY), while the FY2025 annual figure was $303627.0, up 611.1% from the prior year.
• Operating Leases for Q1 2026 stood at $250075.0, down from $303627.0 in the prior quarter.
• The five-year high for Operating Leases was $303627.0 in Q4 2025, with the low at $42698.0 in Q4 2024.
• The 3-year median for Operating Leases is $250075.0 (2026), against an average of $198800.0.
• Peak annual rise in Operating Leases reached 611.1% in 2025, while the deepest fall reached 611.1% in 2025.
• TuHURA Biosciences' Operating Leases stood at $42698.0 in 2024, then soared by 611.1% to $303627.0 in 2025, then retreated by 17.64% to $250075.0 in 2026.
• Business Quant data shows HURA's Operating Leases at $250075.0 in Q1 2026, $303627.0 in Q4 2025, and $42698.0 in Q4 2024.